Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study (Q34336219)

1 August 2017

Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study (English)

1 reference

1 August 2017

1 reference

1 reference

9

Jean Wactawski-Wende

1 reference

1 August 2017

Jane A Cauley

4

0 references

Polly A Newcomb

13

object named as

Polly A Newcomb

1 reference

1 August 2017

2

JoAnn E Manson

1 reference

1 August 2017

6

Marcia L Stefanick

1 reference

1 August 2017

1

Rowan T Chlebowski

1 reference

1 August 2017

3

Garnet L Anderson

1 reference

1 August 2017

7

Dorothy S Lane

1 reference

1 August 2017

5

Aaron K Aragaki

1 reference

1 August 2017

12

Shagufta Yasmeen

1 reference

1 August 2017

Karen C Johnson

8

1 reference

1 August 2017

Chu Chen

10

1 reference

1 August 2017

Lihong Qi

11

1 reference

1 August 2017

Ross L Prentice

14

1 reference

1 August 2017

language of work or name

English

0 references

publication date

29 March 2013

1 reference

Journal of the National Cancer Institute

1 August 2017

1 reference

1 August 2017

105

1 reference

1 August 2017

8

1 reference

1 August 2017

526-535

1 reference

Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Changing concepts: Menopausal hormone therapy and breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

The 2012 hormone therapy position statement of: The North American Menopause Society

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Personalized estimates of breast cancer risk in clinical practice and public health

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Breast cancer risk in relation to the interval between menopause and starting hormone therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Histological, molecular and functional subtypes of breast cancers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Hormone therapy and fatal breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Recent changes in breast cancer incidence in Spain, 1980-2004.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Molecular subtypes of breast cancers detected in mammography screening and outside of screening

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Prognostic role of detection method and its relationship with tumor biomarkers in breast cancer: the university of Texas M.D. Anderson Cancer Center experience

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Prediagnostic use of hormone therapy and mortality after breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Estrogen plus progestin therapy and breast cancer in recently postmenopausal women

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Mortality following development of breast cancer while using oestrogen or oestrogen plus progestin: a computer record-linkage study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Influence of HRT on prognostic factors for breast cancer: a systematic review after the Women's Health Initiative trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Concordance of self-reported data and medical record audit for six cancer screening procedures

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691942

Implementation of the women's health initiative study design

6 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT043

Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT043

Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT043

Adjusting for screening history in epidemiologic studies of cancer: why, when, and how to do it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT043

Improved breast cancer survival among hormone replacement therapy users is durable after 5 years of additional follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT043

Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT043

Postmenopausal Serum Sex Steroids and Risk of Hormone Receptor-Positive and -Negative Breast Cancer: a Nested Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT043

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT043

Postmenopausal Hormone Use, Screening, and Breast Cancer: Characterization and Control of a Bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT043

[Incidence of breast cancer before and after implementation of mammography screening]

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23543779

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The EMAS 2008 update on clinical recommendations on postmenopausal hormone replacement therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23543779

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23543779

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JNCI/DJT043

1 reference

1 August 2017

1 reference

1 August 2017

1 reference